| 1. |
|
|
| 2. |
|
|
| 3. |
- Sbarra, AN, et al.
(författare)
-
Mapping routine measles vaccination in low- and middle-income countries
- 2021
-
Ingår i: Nature. - : Springer Science and Business Media LLC. - 1476-4687 .- 0028-0836. ; 589:7842, s. 415-
-
Tidskriftsartikel (refereegranskat)abstract
- The safe, highly effective measles vaccine has been recommended globally since 1974, yet in 2017 there were more than 17 million cases of measles and 83,400 deaths in children under 5 years old, and more than 99% of both occurred in low- and middle-income countries (LMICs)1–4. Globally comparable, annual, local estimates of routine first-dose measles-containing vaccine (MCV1) coverage are critical for understanding geographically precise immunity patterns, progress towards the targets of the Global Vaccine Action Plan (GVAP), and high-risk areas amid disruptions to vaccination programmes caused by coronavirus disease 2019 (COVID-19)5–8. Here we generated annual estimates of routine childhood MCV1 coverage at 5 × 5-km2pixel and second administrative levels from 2000 to 2019 in 101 LMICs, quantified geographical inequality and assessed vaccination status by geographical remoteness. After widespread MCV1 gains from 2000 to 2010, coverage regressed in more than half of the districts between 2010 and 2019, leaving many LMICs far from the GVAP goal of 80% coverage in all districts by 2019. MCV1 coverage was lower in rural than in urban locations, although a larger proportion of unvaccinated children overall lived in urban locations; strategies to provide essential vaccination services should address both geographical contexts. These results provide a tool for decision-makers to strengthen routine MCV1 immunization programmes and provide equitable disease protection for all children.
|
|
| 4. |
- Abbafati, Cristiana, et al.
(författare)
-
- 2020
-
Tidskriftsartikel (refereegranskat)
|
|
| 5. |
- Kinyoki, DK, et al.
(författare)
-
Mapping child growth failure across low- and middle-income countries
- 2020
-
Ingår i: Nature. - : Springer Science and Business Media LLC. - 1476-4687 .- 0028-0836. ; 577:7789, s. 231-
-
Tidskriftsartikel (refereegranskat)abstract
- Childhood malnutrition is associated with high morbidity and mortality globally1. Undernourished children are more likely to experience cognitive, physical, and metabolic developmental impairments that can lead to later cardiovascular disease, reduced intellectual ability and school attainment, and reduced economic productivity in adulthood2. Child growth failure (CGF), expressed as stunting, wasting, and underweight in children under five years of age (0–59 months), is a specific subset of undernutrition characterized by insufficient height or weight against age-specific growth reference standards3–5. The prevalence of stunting, wasting, or underweight in children under five is the proportion of children with a height-for-age, weight-for-height, or weight-for-age z-score, respectively, that is more than two standard deviations below the World Health Organization’s median growth reference standards for a healthy population6. Subnational estimates of CGF report substantial heterogeneity within countries, but are available primarily at the first administrative level (for example, states or provinces)7; the uneven geographical distribution of CGF has motivated further calls for assessments that can match the local scale of many public health programmes8. Building from our previous work mapping CGF in Africa9, here we provide the first, to our knowledge, mapped high-spatial-resolution estimates of CGF indicators from 2000 to 2017 across 105 low- and middle-income countries (LMICs), where 99% of affected children live1, aggregated to policy-relevant first and second (for example, districts or counties) administrative-level units and national levels. Despite remarkable declines over the study period, many LMICs remain far from the ambitious World Health Organization Global Nutrition Targets to reduce stunting by 40% and wasting to less than 5% by 2025. Large disparities in prevalence and progress exist across and within countries; our maps identify high-prevalence areas even within nations otherwise succeeding in reducing overall CGF prevalence. By highlighting where the highest-need populations reside, these geospatial estimates can support policy-makers in planning interventions that are adapted locally and in efficiently directing resources towards reducing CGF and its health implications.
|
|
| 6. |
|
|
| 7. |
|
|
| 8. |
- Lennon, J. T., et al.
(författare)
-
Priorities, opportunities, and challenges for integrating microorganisms into Earth system models for climate change prediction
- 2024
-
Ingår i: mBio. - 2161-2129 .- 2150-7511.
-
Tidskriftsartikel (refereegranskat)abstract
- Climate change jeopardizes human health, global biodiversity, and sustainability of the biosphere. To make reliable predictions about climate change, scientists use Earth system models (ESMs) that integrate physical, chemical, and biological processes occurring on land, the oceans, and the atmosphere. Although critical for catalyzing coupled biogeochemical processes, microorganisms have traditionally been left out of ESMs. Here, we generate a "top 10" list of priorities, opportunities, and challenges for the explicit integration of microorganisms into ESMs. We discuss the need for coarse-graining microbial information into functionally relevant categories, as well as the capacity for microorganisms to rapidly evolve in response to climate-change drivers. Microbiologists are uniquely positioned to collect novel and valuable information necessary for next-generation ESMs, but this requires data harmonization and transdisciplinary collaboration to effectively guide adaptation strategies and mitigation policy.
|
|
| 9. |
- Thota, S., et al.
(författare)
-
Unraveling the nature of ferrimagnetism and associated exchange interactions in distorted honeycomb Ni4Nb2O9
- 2022
-
Ingår i: Physical Review B. - : American Physical Society. - 2469-9950 .- 2469-9969. ; 106:13
-
Tidskriftsartikel (refereegranskat)abstract
- Ferrimagnetism in orthorhombic Ni4Nb2O9 below its Neel temperature, T-FN similar to 76K is reported to result from two inequivalent Ni2+ ions having different magnetic moments. However, a clear understanding of the temperature variation of its magnetization [M(T)] for T > T-FN and T < T-FN in terms of a single set of exchange parameters is still lacking. In this work, experimental results obtained from a detailed analysis of the temperature and magnetic field dependence of magnetization [M(T, H)], ac-magnetic susceptibility [chi(ac)( f, T, H)], and heat-capacity [C-P(T, H)] measurements are combined with theoretical analysis to provide new insights into the nature of ferrimagnetism in Ni4Nb2O9. X-ray diffraction/Rietveld analysis of the prepared sample yielded the structural parameters of the orthorhombic crystal in agreement with previous studies, whereas x-ray photoelectron spectroscopy confirmed the Ni2+ and Nb5+ electronic states in Ni4Nb2O9. Analysis of chi(ac)(T) shows the paramagnetic-to-ferrimagnetic transition occurs at 76.5 K (T-FN), which increases with applied field H as T-FN proportional to H-0.35 due to the coupling of the ferromagnetic component with H. For T > T-FN, the chi(dc) versus T data are fitted to the Neel's expression for ferrimagnets, yielding the g-factors for the two Ni2+ ions as g(A) = 2.47 and g(B) = 2.10. Also, the antiferromagnetic molecular field constants between the A and B sublattices were evaluated as N-AA = 26.31, N-BB = 8.59, and N-AB = 43.06, which, in turn, yield the antiferromagnetic exchange parameters: J(AA)/k(B) = 4.27 K, J(BB)/k(B) = 1.40 K, and J(AB)/k(B) = 6.98 K. For T < T-FN, the M versus T data clearly show the magnetic compensation point at T-COM similar to 33 K. The mathematical model presented here using the magnitudes of NAA, NBB, and NAB correctly predicts the position of T-COM as well the temperature variation of M both above and below T-COM. The data of C-P(T) versus T shows a lambda-type anomaly across T-FN. After subtracting the lattice contribution, the C-P(T) data are fitted to C-P = A(T - T-N)((-alpha)) yielding the critical exponent alpha = 0.14(0.12) for T < T-FN (T > T-FN), which is a characteristic of second-order phase transition. Magnetic entropy changes determined from the M-H isotherms shows that the applied field H enhances the magnetic ordering for T > T-FN and T < T-COM, but for T-COM < T < T-FN, the spin disorder increases with the increase in H. The temperature variation of the measured coercivity H-C(T) and remanence M-R(T) from 1.9 K to T-FN initially show a decreasing trend, becoming zero at T-COM, then followed by an increase and eventually becoming zero again at T-FN.
|
|
| 10. |
|
|
| 11. |
|
|
| 12. |
|
|
| 13. |
- Birdsell, D. N., et al.
(författare)
-
Coinfections identified from metagenomic analysis of cervical lymph nodes from tularemia patients
- 2018
-
Ingår i: BMC Infectious Diseases. - : BMC. - 1471-2334. ; 18
-
Tidskriftsartikel (refereegranskat)abstract
- Background: Underlying coinfections may complicate infectious disease states but commonly go unnoticed because an a priori clinical suspicion is usually required so they can be detected via targeted diagnostic tools. Shotgun metagenomics is a broad diagnostic tool that can be useful for identifying multiple microbes simultaneously especially if coupled with lymph node aspirates, a clinical matrix known to house disparate pathogens. The objective of this study was to analyze the utility of this unconventional diagnostic approach (shotgun metagenomics) using clinical samples from human tularemia cases as a test model. Tularemia, caused by the bacterium Francisella tularensis, is an emerging infectious disease in Turkey. This disease commonly manifests as swelling of the lymph nodes nearest to the entry of infection. Because swollen cervical nodes are observed from many different types of human infections we used these clinical sample types to analyze the utility of shotgun metagenomics.Methods: We conducted an unbiased molecular survey using shotgun metagenomics sequencing of DNA extracts from fine-needle aspirates of neck lymph nodes from eight tularemia patients who displayed protracted symptoms. The resulting metagenomics data were searched for microbial sequences (bacterial and viral).Results: F. tularensis sequences were detected in all samples. In addition, we detected DNA of other known pathogens in three patients. Both Hepatitis B virus (HBV) and Human Parvovirus B-19 were detected in one individual and Human Parvovirus B-19 alone was detected in two other individuals. Subsequent PCR coupled with Sanger sequencing verified the metagenomics results. The HBV status was independently confirmed via serological diagnostics, despite evading notice during the initial assessment.Conclusion: Our data highlight that shotgun metagenomics of fine-needle lymph node aspirates is a promising clinical diagnostic strategy to identify coinfections. Given the feasibility of the diagnostic approach demonstrated here, further steps to promote integration of this type of diagnostic capability into mainstream clinical practice are warranted.
|
|
| 14. |
|
|
| 15. |
- Kümpornsin, Krittikorn, et al.
(författare)
-
Generation of a mutator parasite to drive resistome discovery in Plasmodium falciparum
- 2023
-
Ingår i: Nature Communications. - : Springer Nature. - 2041-1723. ; 14:1
-
Tidskriftsartikel (refereegranskat)abstract
- In vitro evolution of drug resistance is a powerful approach for identifying antimalarial targets, however, key obstacles to eliciting resistance are the parasite inoculum size and mutation rate. Here we sought to increase parasite genetic diversity to potentiate resistance selections by editing catalytic residues of Plasmodium falciparum DNA polymerase δ. Mutation accumulation assays reveal a ~5–8 fold elevation in the mutation rate, with an increase of 13–28 fold in drug-pressured lines. Upon challenge with the spiroindolone PfATP4-inhibitor KAE609, high-level resistance is obtained more rapidly and at lower inocula than wild-type parasites. Selections also yield mutants with resistance to an “irresistible” compound, MMV665794 that failed to yield resistance with other strains. We validate mutations in a previously uncharacterised gene, PF3D7_1359900, which we term quinoxaline resistance protein (QRP1), as causal for resistance to MMV665794 and a panel of quinoxaline analogues. The increased genetic repertoire available to this “mutator” parasite can be leveraged to drive P. falciparum resistome discovery.
|
|
| 16. |
|
|
| 17. |
|
|
| 18. |
|
|
